TBRG News & Events

In a notice to the BSE Limited, IKS Health stated: "This is with reference to your email dated April 13, 2026 seeking clarification on the news item published on April 13, 2026 in The Economic Times. We would like to clarify that the Company regularly evaluates strategic opportunities in the ordinary course of business, including bidding for potential strategic transactions through its subsidiaries, with or without exclusivity, such as in the captioned news. In furtherance to the foregoing, one of the wholly owned subsidiaries of the Company participated in discussions with TruBridge, Inc. in relation to a potential acquisition of TruBridge. As on date, no definitive or binding agreements have been executed for such potential transaction. The aforesaid discussions remain non-binding and are subject to various contingencies, including ongoing negotiations, requisite approvals (including board approvals) and execution of definitive agreements. There can be no assurance that any transaction will be consummated or as to the terms or timing thereof. The Company will make appropriate disclosures only as and when there are material developments requiring disclosure under the applicable regulations."

The major averages started the week with an advance as investors shook off the weekend collapse in peace negotiations.Crude oil briefly surged past $100 per barrel once again after President Trump announced a blockade of the Strait of Hormuz after peace talks between the U.S. and Iran ended without an agreement in place, but oil pulled back as the session went on.In addition to navigating the renewed Iran worries, stocks advanced in spite of Goldman Sachs- the first of this week's big bank earnings reporters - slipping about 2%.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Goldman Sachsreported, though the company noted that the macro environment started to weigh on sentiment as Q1 progressedFastenalreportedand provided its outlook for 2026Baker Hughesits Waygate Technologies business to Hexagonfor $1.45BSomnigroupLeggett & Plattin a $2.5B all-stock transactionOver 1,000 writers, actors, and directors haveopposing Paramount Skydance'sproposed takeover of Warner Bros. Discovery2. WALL STREET CALLS:Best Buyto Sell from Buy at Goldman SachsKeyBancT-Mobileon valuation, Q1 results catalystStarbucksto Hold at JefferiesConstellation Brandsto Buy at TD CowenNiketo Hold from Buy at HSBC3. AROUND THE WEB:Take-Two'sRockstar Games was hacked for the second time in three years, BBC reportsBooking.comexperienced a data breach with "unauthorized parties" gaining access to customer data, The Guardian saysPolyPeptideis attracting private equity takeover interest, with EQT, KKR, and Advent among suitors looking into a potential acquisition of the company, Bloomberg reportsMetais developing an AI version of Mark Zuckerberg that can interact with employees in his stead as part of a bigger effort to remake the company around AI, FT saysInventurus Knowledge Solutions, or IKS, is in advanced talks to acquire TruBridgefor about $600M, Economic Times says4. MOVERS:Allogene Therapeuticswas higher afterfrom its ALPHA3 trialRevolution Medicinesincreased afterfrom its RASolute 302 clinical trialSpyre Therapeuticsgained after reporting its trial of SPY001Dutch Brosand Black Rock Coffee Barwere lower after the Wall Street Journalthat McDonald'sis planning to offer energy drinksCoStarfell after ReutersThird Point disposed of its position in the company and won't seek a proxy fight5. EARNINGS/GUIDANCE:Children's Place, with EPS and revenue lower year-over-yearMarti Technologiesbacked itsJPMorgan & Chasewillon April 14ALT5 Sigma CorporationreportedTSMCwillon April 16INDEXES:The Dow rose 301.68, or 0.63%, to 48,218.25, the Nasdaq gained 280.84, or 1.23%, to 23,183.74, and the S&P 500 advanced 69.35, or 1.02%, to 6,886.24.

The major averages were mixed near noon - with the Nasdaq trading slightly higher, the Dow lower, and the S&P 500 little changed - as investors adjust to a renewed U.S.-Iran escalation scenario and weigh an early slate of corporate earnings, including from Goldman Sachs. Markets are starting the week on the back foot after the weekend collapse in peace negotiations.Crude oil has surged past $100 per barrel once again as President Trump announced a blockade of the Strait of Hormuz after peace talks between the U.S. and Iran ended without an agreement in place. The breakdown of talks has reignited concerns that the war in Iran will last longer than feared.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Goldman Sachsreported, though the company noted that the macro environment started to weigh on sentiment as Q1 progressedFastenalreportedand provided its outlook for 2026Baker Hughesits Waygate Technologies business to Hexagonfor $1.45BSomnigroupLeggett & Plattin a $2.5B all-stock transactionOver 1,000 writers, actors, and directors haveParamount Skydance'sproposed takeover of Warner Bros. Discovery2. WALL STREET CALLS:Best Buyto Sell from Buy at Goldman SachsKeyBancT-Mobileon valuation, Q1 results catalystStarbucksto Hold at JefferiesConstellation Brandsto Buy at TD CowenNiketo Hold from Buy at HSBC3. AROUND THE WEB:Booking.comexperienced a data breach with "unauthorized parties" gaining access to customer data, The Guardian saysPolyPeptideis attracting private equity takeover interest, with EQT, KKR, and Advent among suitors looking into a potential acquisition of the company, Bloomberg reportsMetais developing an AI version of Mark Zuckerberg that can interact with employees in his stead as part of a bigger effort to remake the company around AI, FT saysSoftbankhas formed a company to build a foundation model for "physical AI", which autonomously controls robots and machines, in Japan through a public-private partnership, Nikkei Asia reportsInventurus Knowledge Solutions, or IKS, is in advanced talks to acquire TruBridgefor about $600M, Economic Times says4. MOVERS:Allogene Therapeuticshigher after reporting data from itsRevolution Medicinesincreases after announcing topline results from itsSpyre Therapeuticsgains after reporting its trial of SPY001Conagra Brandslower afterCoStarfalls afterThird Point disposed of its position in the company and won't seek a proxy fight5. EARNINGS/GUIDANCE:Children's Place, with EPS and revenue lower year-over-yearMarti Technologiesfor FY26JPMorgan & Chaseon April 14ALT5 Sigma CorporationTSMCon April 16INDEXES:Near midday, the Dow was down 0.49%, or 233.91, to 47,682.66, the Nasdaq was up 0.21%, or 47.37, to 22,950.26, and the S&P 500 was up 0.01%, or 0.67, to 6,817.56.

RBC Capital analyst Ryan Halsted notes TruBridge's shares are trading up on media reports of a potential acquisition by IKS Health for $600M. The firm notes the company had announced a strategic review back on March 31 to maximize shareholder value and sees this acquisition as fitting this objective from a strategic and valuation perspective. Strategically, RBC notes IKS Health has invested in tech-enabled revenue cycle management companies and likely can offer infusion of technology and AI capabilities into TruBridge, the firm says. Additionally, RBC points out that there is some prior connection between IKS Health and TruBridge's new Chief Business Officer, who helped orchestrate the sale of AQuity to IKS in 2023. The firm has a Sector Perform rating on TruBridge with a price target of $23.